WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C07 BETA BLOCKING AGENTS
C07A BETA BLOCKING AGENTS

All plain beta blocking agents are classified in this group. Combination packages containing two different products (e.g. sotalol tablets and aspirin tablets in a combination package) are also classified in this group.

Labetalol, and carvedilol are classified in C07AG - Alpha- and beta blocking agents.

Beta blocking agents in combination with ACE inhibitors are classified in C09BX - ACE inhibitors, other combinations.

Beta blocking agents in combination with angiotensin II antagonists are classified in C09DX - Angiotensin II antagonists, other combinations.

The DDDs are based on the treatment of mild-moderate hypertension.

The DDDs for oral and parenteral formulations are equal, even if the parenteral preparations are used for the initial treatment of arrhythmias. Exception: practolol.


C07AA Beta blocking agents, non-selective

All plain non-selective beta blocking agents are classified in this group.
Combined packages containing sotalol tablets and aspirin tablets are classified in C07AA57.


    ATC code  Name  DDD  U Adm.R Note
    C07AA07 sotalol 0.16 
    0.16 

List of abbreviations

Last updated: 2017-12-20